PIMREG and cardiovascular disorder: We hypothesized that the progression of CKD and its related systemic inflammatory state is associated with increasing levels of circulating Cat-S, a protease involved in the pathogenesis of cardiovascular disease and a potential therapeutic target to attenuate atherosclerosis in CKD19.